~~<i id='5294DAC2A0'><strike id='5294DAC2A0'><tt id='5294DAC2A0'><pre id='5294DAC2A0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：entertainment 2025-09-05 11:14:30 - browse：6

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

explore

hotspot

Wikipedia

focus

AdobeJustasanewwaveofapproveddrugsforAlzheimer’sdiseasereachespatients,medicaldevicecompanyCognitoTh

WSS

Congressmen charge Covid hearing ‘could have been an email’

Congressmen charge Covid hearing ‘could have been an email’

First medicine developed to treat MASH expected to be approved soon

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

A $475,000 price tag for a new cancer drug: crazy or meh?

With psoriasis trial ahead, Alumis raises $259 million

explore

fashion

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

CDC marks new Covid

Anesthesiologist group: stop taking Ozempic before surgery

The drug industry has found itself all alone in Washington

Tori Bowie and the unacceptable rates of Black maternal death

RSV shot was 90% effective at preventing hospitalizations in kids

Medical leaders decry Supreme Court decision on affirmative action

Cognito secures funding to test medical device for Alzheimer's

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Do digital therapeutics have a future in medicine?

hotspot

Cybersecurity threat forces Lurie Children's to take systems offline

Apple Vision Pro: A first look at health apps on the new VR headset

Juul spent big to court Black leaders to promote its e

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Sen. Paul opposes bill to ban Chinese biotechs

Wikipedia

Wikipedia

focus

focus